Anti-mucin 1 chimeric antigen receptor T cells for adoptive T cell therapy of cholangiocarcinoma
Abstract Current treatments for cholangiocarcinoma (CCA) are largely unsuccessful due to late diagnosis at advanced stage, leading to high mortality rate. Consequently, improved therapeutic approaches are urgently needed. Chimeric antigen receptor (CAR) T cell therapy is a newly potential therapy th...
Main Authors: | Kamonlapat Supimon, Thanich Sangsuwannukul, Jatuporn Sujjitjoon, Nattaporn Phanthaphol, Thaweesak Chieochansin, Naravat Poungvarin, Sopit Wongkham, Mutita Junking, Pa-thai Yenchitsomanus |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-03-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-85747-9 |
Similar Items
-
Chimeric Antigen Receptor T Cells Targeting Integrin αvβ6 Expressed on Cholangiocarcinoma Cells
by: Nattaporn Phanthaphol, et al.
Published: (2021-03-01) -
Enhanced cytotoxic activity of effector T-cells against cholangiocarcinoma by dendritic cells pulsed with pooled mRNA
by: Mutita Junking, et al.
Published: (2017-10-01) -
GD2-specific chimeric antigen receptor-modified T cells targeting retinoblastoma – assessing tumor and T cell interaction
by: Jatuporn Sujjitjoon, et al.
Published: (2021-02-01) -
A novel predictive equation for potential diagnosis of cholangiocarcinoma.
by: Ratthaphol Kraiklang, et al.
Published: (2014-01-01) -
Intrahepatic mucinous cholangiocarcinoma
by: Bor‐Yow Lin, et al.
Published: (2020-09-01)